Chiral LC-MS/MS method for the simultaneous determination of (R,S)-ketamine, (R,S)-norketamine, and (2R,6R;2S,6S)-hydroxynorketamine in mouse plasma and brain
Journal of Pharmaceutical and Biomedical Analysis · 2023-02 · 224 · 115168
DOI: 10.1016/j.jpba.2022.115168 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical and Biomedical Analysis, 2023-02. Verfasst von Hidetoh Toki und 3 weiteren Autor:innen. Beteiligte Einrichtung: Drug Metabolism and Pharmacokinetics, Drug Safety and Pharmacokinetics Laboratories Taisho Pharmaceutical Co., Ltd., 1-403, Yoshino-cho, Kita-ku, Sai…. Hauptthemen laut MEDLINE: Ketamine. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
A convenient LC-MS/MS assay method to simultaneously and sensitively determine (R,S)-ketamine (Ket), (R,S)-norketamine (NK), and (2R,6R;2S,6S)-hydroxynorketamine (HNK) enantiomers in plasma and brain from mice was developed. This method enables the chiral separations of these six enantiomers in one analysis by constructing a column-switching system composed of one achiral column and two chiral columns with a relatively short analysis time (17 min). The chromatography involves the separation of (2R,6R;2S,6S)-HNK from (R,S)-Ket and (R,S)-NK on an octadecyl-silica column, followed by chiral separations on a CHIRALPAK AY-RH column for (2R,6R;2S,6S)-HNK or on a CHIRALPAK AS-RH column for the other analytes. The calibration curves for plasma and brain showed a good linearity in the range of 3-1000 ng/mL and 1.5-500 ng/g, respectively. The accuracy ranged from 90.0% to 104.0% in within-run and between-run. This validated method was applicable to determine the stereoselective pharmacokinetic profiles of (R,S)-Ket, (R,S)-NK, and (2R,6R;2S,6S)-HNK in plasma and brain collected from individual mice after a single intraperitoneal dosing of racemic Ket at an antidepressant dose. It is hoped that this assay will greatly help for understanding the relationship between the antidepressant actions of (R,S)-Ket enantiomers or their metabolites and their pharmacokinetics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Drug Metabolism and Pharmacokinetics, Drug Safety and Pharmacokinetics Laboratories Taisho Pharmaceutical Co., Ltd., 1-403, Yoshino-cho, Kita-ku, Saitama-shi, Saitama 331-9530, Japan. Electronic address: h-toki@taisho.c…
- Drug Metabolism and Pharmacokinetics, Drug Safety and Pharmacokinetics Laboratories Taisho Pharmaceutical Co., Ltd., 1-403, Yoshino-cho, Kita-ku, Saitama-shi, Saitama 331-9530, Japan.
Zitieren
APA
Toki, H., Yamaguchi, J. I., Mizuno-Yasuhira, A., & Endo, H. (2023). Chiral LC-MS/MS method for the simultaneous determination of (R,S)-ketamine, (R,S)-norketamine, and (2R,6R;2S,6S)-hydroxynorketamine in mouse plasma and brain. Journal of Pharmaceutical and Biomedical Analysis, 224, 115168. https://doi.org/10.1016/j.jpba.2022.115168
Vancouver
Toki H, Yamaguchi JI, Mizuno-Yasuhira A, Endo H. Chiral LC-MS/MS method for the simultaneous determination of (R,S)-ketamine, (R,S)-norketamine, and (2R,6R;2S,6S)-hydroxynorketamine in mouse plasma and brain. Journal of Pharmaceutical and Biomedical Analysis. 2023;224:115168. doi:10.1016/j.jpba.2022.115168
BibTeX
@article{Toki2023,
author = {Toki, Hidetoh and Yamaguchi, Jun-Ichi and Mizuno-Yasuhira, Akiko and Endo, Hiromi},
title = {Chiral LC-MS/MS method for the simultaneous determination of (R,S)-ketamine, (R,S)-norketamine, and (2R,6R;2S,6S)-hydroxynorketamine in mouse plasma and brain},
journal = {Journal of Pharmaceutical and Biomedical Analysis},
year = {2023},
volume = {224},
pages = {115168},
doi = {10.1016/j.jpba.2022.115168}
}
EUVIMED